Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.
Mao-Draayer Y, Bar-Or A, Balashov K, Foley J, Smoot K, Longbrake EE, Robertson D, Mendoza JP, Lewin JB, Everage N, Božin I, Lyons J, Mokliatchouk O, Bame E, Giuliani F. Mao-Draayer Y, et al. Among authors: bar or a. Adv Ther. 2024 Nov 21. doi: 10.1007/s12325-024-03047-w. Online ahead of print. Adv Ther. 2024. PMID: 39570545
Investigating Mood and Cognition in People with Multiple Sclerosis: A Prospective Study Protocol.
Cooper EC, Schindler MK, Bar-Or A, Brandstadter RB, Calkins ME, Gur RC, Jacobs DA, Markowitz CE, Moore TM, Naydovich LR, Perrone CM, Ruparel K, Spangler BC, Troyan S, Shinohara RT, Satterthwaite TD, Baller EB. Cooper EC, et al. Among authors: bar or a. medRxiv [Preprint]. 2024 Oct 4:2024.10.02.24314787. doi: 10.1101/2024.10.02.24314787. medRxiv. 2024. PMID: 39464257 Free PMC article. Preprint.
Choroid Plexus Volume in Pediatric-Onset Multiple Sclerosis.
Grasso EA, Bloy L, Kaplan P, Bar-Or A, Yeh EA, Arnold DL, Narayanan S, Marrie RA, Fadda G, Banwell BL; Canadian Demyelinating Disease Network. Grasso EA, et al. Among authors: bar or a. Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200319. doi: 10.1212/NXI.0000000000200319. Epub 2024 Oct 23. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39442038 Free PMC article.
Association of Anxiety with Uncinate Fasciculus Lesion Burden in Multiple Sclerosis.
Baller EB, Luo AC, Schindler MK, Cooper EC, Pecsok MK, Cieslak MC, Martin ML, Bar-Or A, Elahi A, Perrone CM, Reid D, Spangler BC, Satterthwaite TD, Shinohara RT. Baller EB, et al. Among authors: bar or a. medRxiv [Preprint]. 2024 Oct 9:2024.10.08.24315108. doi: 10.1101/2024.10.08.24315108. medRxiv. 2024. PMID: 39417125 Free PMC article. Preprint.
Relation of CMV and brain atrophy to trajectories of immunosenescence in diverse populations.
Touil H, Luquez T, Comandante-Lou N, Lee AJ, Fujita M, Habeck C, Kroshilina A, Hegewisch-Solloa E, McInvale J, Zuroff L, Isnard S, Walker E, Zhang L, Routy JP, Zhang Y, Mace EM, Klotz L, Wiendl H, Xia Z, Bar-Or A, Menon V, Stern Y, De Jager PL. Touil H, et al. Among authors: bar or a. bioRxiv [Preprint]. 2024 Nov 21:2024.10.07.614568. doi: 10.1101/2024.10.07.614568. bioRxiv. 2024. PMID: 39416188 Free PMC article. Preprint.
Impact of insurance status on MRI phenotypes in MS.
Martin ML, Robert-Fitzgerald T, Schindler MK, Perrone C, Schultz G, Lynch S, Mirkovic N, Thomas S, Elahi A, Reid D, Moore TM, Baller EB, Satterthwaite TD, Cieslak M, Covitz S, Adebimpe A, Manning A, Markowitz CE, Detre JA, Bar-Or A, Kakara M, Shinohara RT. Martin ML, et al. Among authors: bar or a. Mult Scler Relat Disord. 2024 Oct 9;92:105919. doi: 10.1016/j.msard.2024.105919. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39406154
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.
Derfuss T, Bermel R, Lin CJ, Hauser SL, Kappos L, Vollmer T, Comi G, Giovannoni G, Hartung HP, Weber MS, Wang J, Jessop N, Chognot C, Craveiro L, Bar-Or A. Derfuss T, et al. Among authors: bar or a. Ther Adv Neurol Disord. 2024 Oct 8;17:17562864241277736. doi: 10.1177/17562864241277736. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39399100 Free PMC article.
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.
Kalia LV, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca DG, Fon EA, Fox S, Gan-Or Z, Gommerman JL, Kang UJ, Klawiter EC, Koch M, Kolind S, Lang AE, Lee KK, Lincoln MR, MacDonald PA, McKeown MJ, Mestre TA, Miron VE, Ontaneda D, Rousseaux MWC, Schlossmacher MG, Schneider R, Stoessl AJ, Oh J. Kalia LV, et al. Among authors: bar or a. Nat Rev Neurol. 2024 Dec;20(12):724-737. doi: 10.1038/s41582-024-01023-0. Epub 2024 Oct 7. Nat Rev Neurol. 2024. PMID: 39375563 Review.
Multicenter automated central vein sign detection performs as well as manual assessment for the diagnosis of multiple sclerosis.
Manning AR, Letchuman V, Martin ML, Gombos E, Roberts-Fitzgerald T, Cao Q, Raza P, O'Donnell CM, Renner B, Daboul L, Rodrigues P, Ramos M, Derbyshire J, Azevedo C, Bar-Or A, Caverzasi E, Calabresi PA, Cree BA, Freeman L, Henry RG, Longbrake EE, Oh J, Papinutto N, Pelletier D, Samudralwar RD, Suthiphosuwan S, Schindler MK, Bilello M, Song JW, Sotirchos ES, Sicotte NL, Al-Louzi O, Solomon AJ, Reich DS, Ontaneda D, Sati P, Shinohara RT; NAIMS Cooperative. Manning AR, et al. Among authors: bar or a. AJNR Am J Neuroradiol. 2024 Sep 27:ajnr.A8510. doi: 10.3174/ajnr.A8510. Online ahead of print. AJNR Am J Neuroradiol. 2024. PMID: 39332906
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Among authors: bar or a. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
413 results